Log in to search using one of your social media accounts:

 

Heart Attack Risk Spikes After Respiratory Infection, Study Finds
Even the common cold was linked to a 13-fold increased risk for about a week Source: HealthDay Related MedlinePlus Pages: Common Cold, Heart Attack, Infectious Diseases (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 16, 2017 Category: Consumer Health News Source Type: news

Heart Attack Risk Spikes After Respiratory Infection, Study Finds
TUESDAY, May 16, 2017 -- The risk of heart attack increases sharply after a respiratory infection, a new study finds. But the absolute risk that any one episode will cause a heart attack is low, the Australian researchers added. The researchers... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 16, 2017 Category: General Medicine Source Type: news

IRRESPONSIBLE: Doctors are prescribing antibiotics for the common cold
(Natural News) A stuffy nose, rattling cough, and fever are the typical symptoms of a common cold. While rest and strengthening the immune system are the best medicines to fight an army of sick-making viruses, many doctors unnecessarily prescribe antibiotics to treat the symptoms of upper respiratory tract infections such as acute bronchitis and the... (Source: NaturalNews.com)
Source: NaturalNews.com - May 16, 2017 Category: Consumer Health News Source Type: news

Staying healthy during WorldPride 2017
(European Centre for Disease Prevention and Control (ECDC)) ECDC has published a rapid risk assessment to assess the risk of outbreaks and transmission of communicable diseases during the WorldPride festival period taking place in Madrid in June 2017. For respiratory and vector-borne diseases, the risk is considered low, for food and waterborne diseases the risk is low to moderate, for vaccine-preventable diseases, it is moderate and for sexually transmitted infections, the risk is moderate to high. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 16, 2017 Category: Infectious Diseases Source Type: news

More than 1.2 million adolescents die every year, nearly all preventable
(Hoffman& Hoffman Worldwide) More than 3000 adolescents die every day, totalling 1.2 million deaths a year, from largely preventable causes, according to a new report from the World Health Organization (WHO) and partners. In 2015, more than two-thirds -- some 855,000 10- to 19-year-olds -- died in low- and middle-income countries of the African and South-East Asia Regions. Road traffic injuries, lower respiratory infections and suicide are the biggest causes of death among adolescents. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2017 Category: International Medicine & Public Health Source Type: news

Red Meat Increases Risk of Dying From 9 Diseases
High red meat consumption increased the rate of dying from cancer, heart disease, respiratory disease, stroke, diabetes, infections, Alzheimer ’ s disease, kidney disease and liver disease. (Source: NYT Health)
Source: NYT Health - May 15, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Meat Alzheimer's Disease Liver Heart Respiratory Diseases Diabetes Source Type: news

Heart attack risk increases 17-fold following respiratory infections
The risk of having a heart attack is 17 times higher in the seven days following a respiratory infection, research has found. The increased risk peaks in the first 7 days and gradually reduces but remains elevated for one month. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 15, 2017 Category: Science Source Type: news

Database FunResDB - azole resistance (A. fumigatus)
Link: Database linkLink to paper describing database (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 15, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Respiratory infections increase heart attacks by 17 times
Researchers from the University of Sydney found that pneumonia or bronchitis pose the biggest heart attack risk, but even a common cold raises your susceptibility by up to 13.5 times. (Source: the Mail online | Health)
Source: the Mail online | Health - May 15, 2017 Category: Consumer Health News Source Type: news

Genoa raises $62m Series A for inhaled lung drug
Genoa Pharmaceuticals said today that it raised $62 million in a Series A round to support the development of inhaled therapies for idiopathic pulmonary fibrosis and other severe pulmonary conditions. The round was led by F-Prime Capital Partners and Edmond de Rothschild Investment Partners. Novo AS, RiverVest Venture Partners and TPG Biotech also invested in the round. The Seattle-based biotech added that venture capitalists Dr. Ketan Patel, Dr. Naveed Siddiqi, Tiba Aynechi, Niall O’Donnell and Dr. Heather Preston joined the baord of directors. Dr. Bruce Montgomery was named CEO and the company’s founder, Mark...
Source: Mass Device - May 15, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Funding Roundup Pharmaceuticals Respiratory genoapharmaceuticals Source Type: news

Medical News Today: Respiratory infections raise heart attack risk by 17 times
A new study suggests that during the first 7 days of a respiratory infection, the risk of having a heart attack is 17 times higher. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 15, 2017 Category: Consumer Health News Tags: Heart Disease Source Type: news

omalizumab, Xolair
Title: omalizumab, XolairCategory: MedicationsCreated: 5/27/2004 12:00:00 AMLast Editorial Review: 5/15/2017 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - May 15, 2017 Category: Respiratory Medicine Source Type: news

Heart attack risk increases 17-fold following respiratory infections
(University of Sydney) The risk of having a heart attack is 17 times higher in the seven days following a respiratory infection, University of Sydney research has found. The increased risk peaks in the first 7 days and gradually reduces but remains elevated for one month. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 15, 2017 Category: Infectious Diseases Source Type: news

What Causes Anemia?
Discussion One of the most common problems in pediatrics is anemia. It is defined as “a lower than normal value for the related measurements of hemoglobin, hematocrit, and number of red blood cells”, usually 2 standard deviations below the normal for age. Normal hematological values change with age. For a discussion of which values are used click here. The most common type of anemia in childhood is iron deficiency which is commonly caused by inadequate stores (e.g. premature infant), inadequate intake (e.g. poor nutrition) or blood loss (e.g. menses). Anemia screening is recommended at age 9-12 months, and for...
Source: PediatricEducation.org - May 15, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Australian research company buys OP facility to create U.S. footprint
An Australia-based global clinical research organization will create its U.S. foothold by acquiring Vector Oncology's Pharma Services division in Overland Park. Vector Oncology’s scientific trials and medical operations are based in Memphis, but its Pharma Services division is in Overland Park. The acquisition will bring Vector Oncology’s trial delivery solutions to the Asia-Pacific region, while expanding George Clinical’s expertise in vascular, re nal respiratory diseases and neurology in… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 12, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

Scientists create lung organoids that mimic full-size lung
Researchers at Columbia University have created lung organoids to mimic features of a full-sized lung to give a better understanding of respiratory diseases. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 12, 2017 Category: Consumer Health News Source Type: news

Enhanced Recovery After Surgery Program Ups Outcomes
Lower hospital length of stay and postoperative complication rates after implementation of ERAS (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 12, 2017 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Gynecology, Internal Medicine, Critical Care, Nephrology, Nursing, Ophthalmology, Orthopedics, ENT, Pulmonology, Surgery, Anesthesiology & Pain, Urology, Journal, Source Type: news

New lung 'organoids' in a dish mimic features of full-size lung
(Columbia University Medical Center) New lung 'organoids' -- tiny 3-D structures that mimic features of a full-sized lung -- have been created from human pluripotent stem cells by researchers at Columbia University Medical Center (CUMC). The team used the organoids to generate models of human lung diseases in a lab dish, which could be used to advance our understanding of a variety of respiratory diseases. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 12, 2017 Category: Biology Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 11, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Propeller Health: From hardware startup to analytics leader Seven years after the digital respiratory startup Propeller Health launched, co-founder and chief technology officer Greg Tracy told a crowd at this year’s Medic...
Source: Mass Device - May 11, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Multidrug - Resistant TB Set to Increase Through 2040
Increase in percentage of MDR tuberculosis, XDR tuberculosis in India, Philippines, Russia, S. Africa (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 11, 2017 Category: Respiratory Medicine Tags: Infections, Internal Medicine, Nursing, Pathology, Pulmonology, Journal, Source Type: news

Outcomes Up With Same Hospital Readmissions in Heart Failure
Continuity of care may be more important than speedy treatment, researchers say (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 11, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pulmonology, Journal, Source Type: news

Propeller Health: From hardware startup to analytics leader
Seven years after the digital respiratory startup Propeller Health launched, co-founder and chief technology officer Greg Tracy told a crowd at this year’s Medical Sensors Design Conference that what started as an attempt to build sensors for respiratory devices has slowly evolved into a “hardware-enabled software company.” “We thought that we were going to go build devices and drop this magical things in patients’ lives and they were going to get better,” he said. “And we were wrong about that. It turns out that onboarding people and injecting technology into their life isn&r...
Source: Mass Device - May 11, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Respiratory Propeller Health Source Type: news

Add-On Nucala Does, and Doesn't, Reduce COPD Exacerbations
(MedPage Today) -- Significant benefit in METREX trial but not in METREO (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - May 11, 2017 Category: Respiratory Medicine Source Type: news

GSK dodges bullet after another generic Advair competitor is denied
GlaxoSmithKline (NYSE:GSK) will not likely face generic competition to its lung drug Advair in the US this year. Yesterday, the FDA denied the application for a 2nd generic competitor. Hikma Pharmaceuticals (LON:HIK) disclosed today that the FDA decided not to approve its version of the inhaled asthma treatment, due to “major” problems with the application. This comes on the heels of Mylan‘s (NSDQ:MYL) announcement in March that the federal watchdog delayed approval of its Advair generic. Thanks to these 2 rejections, industry analysts believe that the threat of generic competition has...
Source: Mass Device - May 11, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Respiratory Wall Street Beat GlaxoSmithKline plc Hikma Pharmaceuticals PLC Mylan Source Type: news

Deadline for applications to 2nd international clinical mycology master class, Turkey
2nd International Clinical Mycology Master Class: Challenges in Diagnosis and Management of Invasive Fungal Diseases Thursday23 - ­â€ Saturday25, November 2017 Izmir, TurkeyCourses& Workshops (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 11, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

2nd International Clinical Mycology Master Class: Challenges in Diagnosis and Management of Invasive Fungal Diseases
 Thursday23 -­â€ Saturday25, November 2017 Izmir, Turkey.The workshop is intended for clinical microbiologists, medical mycologists, physicians, infectious disease specialists, internists, pediatricians, dermatologists, gynecologists, scientists from academia (or companies), laboratory medicine specialists, postdocs and PhD students who want to improve their knowledge and understanding in the area of clinical mycology. Course language is English. Personal guidance is possible in Turkish, Farsi, Dutch, French, Greek and German.Courses& Workshops (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 11, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Hayfever: clinical review
Why it is important to diagnose and effectively manage seasonal allergic rhinitis, including advice on pre-emptively managing patients, comorbidities and allergen avoidance. (Source: GP Online Education)
Source: GP Online Education - May 11, 2017 Category: Primary Care Tags: 15.8 Respiratory Problems Source Type: news

Bundled Payment Initiative Doesn ’ t Cut Readmission in COPD
Medicare Bundled Payments for Care Improvement doesn't cut costs in COPD exacerbation (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 10, 2017 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Internal Medicine, Emergency Medicine, Nursing, Pulmonology, Journal, Source Type: news

Clinical Benefits for CRT - D Over ICD Even With Comorbidity
Absolute risk reduction associated with CRT - D versus ICD was greater in groups with more comorbidity (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 10, 2017 Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Nursing, Pulmonology, Geriatrics, Journal, Source Type: news

Testosterone Found to Be Protective Against Asthma
Study findings could explain why airway condition is more common in women (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 10, 2017 Category: Respiratory Medicine Tags: Pathology, Pulmonology, Allergy, Journal, Source Type: news

IVC Filters Still a Question Mark for Prevention in Trauma (CME/CE)
(MedPage Today) -- Trends in use don't match up with pulmonary embolism rates (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - May 10, 2017 Category: Respiratory Medicine Source Type: news

Post-Doctoral Position Department of Microbiology and Molecular Genetics
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 10, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

The Medical Mycological Society of the Americas annual meeting
Date: Wednesday, May 10, 2017Year: 2017 (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 10, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Mylan beats Q1 earnings by a penny, misses on revenue
Shares in Mylan (NSDQ:MYL) rose 2% in pre-market activity today after the EpiPen maker beat earnings expectations on Wall Street with its 1st quarter results. The Canonsburg, Penn.-based company posted profits of $66.4 million, or 12¢ per share, on sales of $2.72 billion for the 3 months ended March 31, for bottom-line growth of 377.7% on sales growth of 24.2% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Mylan beats Q1 earnings by a penny, misses on revenue appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 10, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations MassDevice Earnings Roundup Pharmaceuticals Respiratory Wall Street Beat Mylan Source Type: news

Be Clear on Cancer Respiratory Symptoms campaign re-launches
(Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 10, 2017 Category: Drugs & Pharmacology Source Type: news

No Decision on Climate Change Deal Until After G7 Summit: White House
Title: No Decision on Climate Change Deal Until After G7 Summit: White HouseCategory: Health NewsCreated: 5/10/2017 12:00:00 AMLast Editorial Review: 5/10/2017 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - May 10, 2017 Category: Respiratory Medicine Source Type: news

Vitamin D Fails the Asthma Test
Title: Vitamin D Fails the Asthma TestCategory: Health NewsCreated: 5/9/2017 12:00:00 AMLast Editorial Review: 5/10/2017 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - May 10, 2017 Category: Respiratory Medicine Source Type: news

Doctors Without Borders in talks with ResApp to evaluate respiratory disease diagnostic app in rural, low-income settings
International medical organization Doctors Without Borders (M édecins sans Frontières, or MSF) is looking to evaluate the use of an app to diagnose and manage respiratory disease in rural, low-income settings. An unofficial collaboration is already in the works with Australian digital health company ResApp, whom MSF has indicated they are interested in worki ng with in a clinical study. (Source: mobihealthnews)
Source: mobihealthnews - May 9, 2017 Category: Information Technology Source Type: news

OptiNose raises $37m in Series D for commercial efforts
OptiNose said today that it closed a $37 million Series D round led by Fidelity Management and Research Company. Avista Capital Partners, Entrepreneurs Fund and other current investors also contributed to the round. The Yardley, Penn.-based company said it plans to use the newly-acquired funds to support commercial development of its lead product candidate, OPN-375, in the U.S. OptiNose’s 1st commercial product is based on its Breath Powered platform, which the company said it uses to develop new systems capable of deep intranasal deposition of medication. Get the full story at our sister site, Drug Delivery Bus...
Source: Mass Device - May 9, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Pharmaceuticals Respiratory OptiNose Source Type: news

Only 10 Percent of Daily Salt Intake Comes From Shaker
Processed foods, restaurant meals account for most sodium intake in average U.S. diet (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 9, 2017 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nephrology, Neurology, Nursing, Pulmonology, Journal, Source Type: news

2017 Annual Review of Diseases Prioritized Under the Research and Development Blueprint
World Health Organization. 04/03/2017 This 16-page document summarizes a meeting held on January 24-25, 2017, to review the list of priority diseases for the World Health Organization Research and Development (R&D) Blueprint. The R&D Blueprint focuses on severe emerging diseases with potential to generate a public health emergency, and for which insufficient or no preventive and curative solutions exist. The 2017 annual review determined there was an urgent need for research and development for nine diseases, including Filoviral diseases (including Ebola and Marburg); Middle East respiratory syndrome coronavirus (M...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 9, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Forensic case reports presenting immersion pulmonary edema as a differential diagnosis in fatal diving accidents - Vinkel J, Bak P, Juel Thiis Knudsen P, Hyldegaard O.
Immersion Pulmonary Edema (IPE) reduces the transport of gases over the respiratory membrane due to edema in the interstitium and respiratory zones. IPE has previously been described in both swimmers and divers, with a few known fatal cases. We have review... (Source: SafetyLit)
Source: SafetyLit - May 9, 2017 Category: International Medicine & Public Health Tags: Drowning, Suffocation Source Type: news

Medical Writer and Web Manager: Aspergillus Website Team
(Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - May 9, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Middle East respiratory syndrome coronavirus (MERS-CoV)
Middle East respiratory syndrome (MERS) is a viral respiratory illness caused by a coronavirus (Middle East respiratory syndrome coronavirus, or MERS ‐CoV) that was first identified in Saudi Arabia in 2012. Coronaviruses are a large family of viruses that can cause diseases in humans, ranging from the common cold to Severe Acute Respiratory Syndrome (SARS). (Source: WHO Feature Stories)
Source: WHO Feature Stories - May 9, 2017 Category: International Medicine & Public Health Tags: mers cov [subject], Q & A [doctype] Source Type: news